- Investing Ideas
- Japanese Pharmaceuticals & Biotech Too Big To Fail
Japanese Pharmaceuticals & Biotech Too Big To Fail
Results
4
Large established companies which pay a dividend.
4 companies
Astellas Pharma
Market Cap: JP¥3.8t
Engages in the research, development, manufacture, sale, and supply of pharmaceuticals in Japan and internationally.
4503
JP¥2,142.00
7D
-0.2%
1Y
48.9%
Shionogi
Market Cap: JP¥2.4t
Engages in the research, development, manufacture, and distribution of pharmaceuticals, diagnostic reagents, and medical devices in Japan and internationally.
4507
JP¥2,841.00
7D
-1.1%
1Y
14.3%
Kyowa Kirin
Market Cap: JP¥1.4t
Engages in the research, development, manufacturing, and marketing of pharmaceuticals in Japan, the Americas, Europe, Asia, and internationally.
4151
JP¥2,639.50
7D
-1.5%
1Y
5.8%
Ono Pharmaceutical
Market Cap: JP¥1.1t
Produces, purchases, and sells pharmaceuticals and diagnostic reagents worldwide.
4528
JP¥2,388.50
7D
-4.0%
1Y
43.9%